This is in line with studies showing that butyrate has anti-cancer activity [32,55] and a study in the rat insulinoma (RIN) cell line [56], but in contrast to studies in diabetic rodents where butyrate or a HDAC3 inhibitor increased beta cell proliferation [27,57]. Here, HDAC3 is linked to pancreatic insulinoma.